Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | GLP1R | P43220 | 8/20 | 0.47 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | CASP2 | P42575 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24754576 | 1.00 | USP2 (0.50) | USP2CA1CA2GLP1RSIRT6 | |
| SCHEMBL21020133 | 0.97 | GLP1R (0.50) | USP2CA1CA2GLP1RSIRT6 | |
| SCHEMBL29849120 | 0.89 | USP2 (0.50) | USP2CA1CA2SIRT6SIRT1 | |
| SCHEMBL21020147 | 0.88 | CA1 (0.44) | USP2CA1CA2GLP1RNOD1 | |
| SCHEMBL24754575 | 0.84 | USP2 (0.51) | USP2CA1CA2SIRT6SIRT1 | |
| SCHEMBL14253094 | 0.82 | SIRT6 (0.59) | GLP1RSIRT6SIRT1NOD1LPAR3 | |
| SCHEMBL21019823 | 0.82 | USP2 (0.49) | USP2CA1CA2SIRT6SIRT1 | |
| SCHEMBL21020203 | 0.82 | USP2 (0.49) | USP2CA1CA2SIRT6SIRT1 | |
| SCHEMBL19071305 | 0.81 | GLP1R (0.49) | GLP1RSIRT6SIRT1NOD1LPAR3 | |
| SCHEMBL13336948 | 0.81 | GLP1R (0.64) | GLP1RNOD1LPAR3CASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210353511-A1 | GEL STICK COMPOSITIONS | CALUMET SPECIALTY PRODUCTS PARTNERS L P (US) | 2021-11-18 | — | — | US | disclosed |
| EP-2658531-B1 | USE OF GLUTAMIDE STABILIZERS | AVON PROD INC (US) | 2019-05-22 | — | — | EP | disclosed |
| US-20170037219-A1 | PHOTOCURABLE RESIN COMPOSITION, IMAGE DISPLAY DEVICE, AND METHOD FOR PRODUCING SAME | HITACHI CHEMICAL CO LTD (JP) | 2017-02-09 | — | — | US | disclosed |
| US-20160312085-A1 | PHOTO CURABLE RESIN COMPOSITION, IMAGING DISPLAY DEVICE AND PRODUCTION METHOD THEREOF | HITACHI CHEMICAL CO LTD (JP) | 2016-10-27 | — | — | US | disclosed |
| US-9394457-B2 | Photo curable resin composition, imaging display device and production method thereof | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20150368499-A1 | PHOTO CURABLE RESIN COMPOSITION, IMAGING DISPLAY DEVICE AND PRODUCTION METHOD THEREOF | HITACHI CHEMICAL COMPANY, LTD. | 2015-12-24 | — | — | US | disclosed |
| US-9150706-B2 | Photo curable resin composition, imaging display device and production method thereof | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20150257996-A1 | MASCARA COMPOSITIONS WITH ENHANCED DEPTH OF COLOR | AVON PRODUCTS, INC. | 2015-09-17 | — | — | US | disclosed |
| US-20150050509-A1 | PHOTOCURABLE RESIN COMPOSITION, IMAGE DISPLAY DEVICE, AND METHOD FOR PRODUCING SAME | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2015-02-19 | — | — | US | disclosed |
| US-20140284056-A1 | N-ACYL AMINO ACID ALKYLAMIDE IN OIL-BASED PARTICULATE CARRIER FLUIDS FOR WELL TREATMENTS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-09-25 | — | — | US | disclosed |
| US-20140044663-A1 | Use of Glutamide Stabilizers | AVON PRODUCTS, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| US-20130286604-A1 | PHOTO CURABLE RESIN COMPOSITION, IMAGING DISPLAY DEVICE AND PRODUCTION METHOD THEREOF | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2013-10-31 | — | — | US | disclosed |
| US-20120164093-A1 | Use of Glutamide Stabilizers | AVON PRODUCTS, INC. (US) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150257996-A1 | MASCARA COMPOSITIONS WITH ENHANCED DEPTH OF COLOR | CUTA, RARA, GRIA3 | USP2 4236/4885CA1 824/4885CA2 3628/4885 |
| US-20120164093-A1 | Use of Glutamide Stabilizers | GLUL, QPCT, GGH | USP2 1449/4885CA1 633/4885CA2 1890/4885 |
| US-20210353511-A1 | GEL STICK COMPOSITIONS | CAT, EBPL, GPX4 | USP2 1663/4885CA1 4512/4885CA2 3608/4885 |
| US-20140044663-A1 | Use of Glutamide Stabilizers | GLUL, QPCT, GGH | USP2 1449/4885CA1 633/4885CA2 1890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.